首页> 外文期刊>Journal of Drug Delivery and Therapeutics >SYNTHESIS AND COMPARISON OF PEG-IBUPROFEN AND PEG-KETOPROFEN PRODRUGS BY IN VITRO AND IN VIVO EVALUATION
【24h】

SYNTHESIS AND COMPARISON OF PEG-IBUPROFEN AND PEG-KETOPROFEN PRODRUGS BY IN VITRO AND IN VIVO EVALUATION

机译:体内和体外评价合成PEG-布洛芬和PEG-酮洛芬

获取原文
获取外文期刊封面目录资料

摘要

Pain is an unpleasant sensation experienced by all individuals and classified as acute and chronic pain. NSAIDa€?s were most widely used for treatment of Analgesia and Inflammation. Ibuprofen, Ketoprofen, Polyethylene glycol 1500 & PEG 6000 were used as drug carriers and Glycine was used as spacer to link the drugs through ester linkage. Ibuprofen and Ketoprofen belong to propionic acid derivatives of Anti-inflammatory drugs and are non-selective COX inhibitors. PEG 1500/PEG6000-Ibuprofen/Ketoprofen and PEG 1500/PEG 6000-Glycine-Ibuprofen/Ketoprofen were synthesized and are subjected to In Vitro dissolution studies which revealed that the drug release was higher at 7.2 pH rather than at 1.2 pH. The results of In Vivo evaluation studies of both synthesized prodrugs revealed that these prodrugs retained their Analgesic activity by hot plate method and acetic acid method, Anti-inflammatory activity by paw edema method and cotton pellet method. Both the prodrugs had exhibited good ulcer protective activity when compared to parent drugs.
机译:疼痛是所有个体都经历的不愉快的感觉,分为急性和慢性疼痛。 NSAIDa s最广泛用于镇痛和炎症的治疗。布洛芬,酮洛芬,聚乙二醇1500和PEG 6000被用作药物载体,甘氨酸被用作间隔基以通过酯键连接药物。布洛芬和酮洛芬属于抗炎药的丙酸衍生物,并且是非选择性的COX抑制剂。合成了PEG 1500 / PEG6000-布洛芬/酮洛芬和PEG 1500 / PEG 6000-甘氨酸-布洛芬/酮洛芬,并进行了体外溶出研究,结果表明该药物在7.2 pH而不是1.2 pH下释放更高。两种合成前药的体内评价研究结果表明,这些前药通过热板法和乙酸法保持镇痛活性,通过爪水肿法和棉丸法保持抗炎活性。与母体药物相比,两种前药均具有良好的溃疡保护活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号